Type 2 diabetes has been linked with subclinical cardiomyopathy and kidney function decline, therefore short-term non-steroidal anti-inflammatory drug (NSAID) use could potentially lead to the development of heart failure (HF) due to aberrations in fluid balances. In this touchCARDIO interview, we speak with Dr Anders Holt (Herlev and Gentofte Hospital, Copenhagen University Hospital, Hellerup, Denmark) to discuss the purpose and outcomes of a cohort study to assess associations between short-term NSAID use and the risk of HF in Danish cohort of patients with type 2 diabetes.
The abstract entitled ‘Non-steroidal anti-inflammatory drugs linked with heart failure in patients with diabetes’ was presented at the European Society of Cardiology (ESC) Congress 2022, 26 – 29 August 2022.
- What were the aims, design and eligibility criteria of your cohort study? (0:34)
- What were the findings of the study both overall and among individual NSAIDs? (3:44)
- What patient factors were associated with increased risk of heart failure? (6:13)
- What are the implications of these findings for clinical practice? (10:09)
Disclosures: Anders Holt has nothing to disclose in relation to this video interview.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Danielle Crosby.
Filmed as a highlight of ESC 2022
Access more content on Heart Failure here
Share this Video
Related Videos In Heart Failure
Divaka Perera, ESC 2022: Percutaneous revascularisation in patients with severe ischaemic cardiomyopathy, the REVIVED trial
The REVIVED study aimed to assess whether the addition of stents when treating patients with severe ischaemic cardiomyopathy would be beneficial to patient outcomes. In this touchCARDIO interview, we speak with Professor Divaka Perera (King’s College London, London, UK) to discuss the REVIVED trial, its outcomes and how they will affect the current treatment paradigm. […]
Divaka Perera, ESC 2022: The unmet needs in patients with heart failure due to ischaemic cardiomyopathy
In an ideal scenario, patients with ischaemic cardiomyopathy would receive specific treatment options beyond the general heart failure management currently in place. In this touchCARDIO interview, we speak with Professor Divaka Perera (King’s College London, London, UK) to discuss the unmet needs in this population and give an evaluation of surgical and percutaneous revascularization in […]
Caroline Sindet-Pedersen, ESC 2022: SARS-CoV-2 mRNA vaccines in patients with heart failure
Studies investigating the safety and efficacy of the severe acute respiratory syndrome coronavirus 2 infection (SARS-CoV-2) mRNA vaccines lacked representation of patients with heart failure. In this touchCARDIO interview, we speak with Dr Caroline Sindet-Pedersen (Copenhagen University Hospital Herlev and Gentofte, Hellerup, Denmark) to discuss the study presented at ESC 2022 that aimed to investigate […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!